|
|
|
33635 |
 |
2021: Macrophages are a portal to breast cancer metastasis and appears from piecing together studies are formed by Mena pro angiogenic macrophages and endothelial cell cd206 mannose receptor M2 in the TME |
GN |
moneyonomics
|
|
3 |
1/26/2021 9:04:10 PM |
|
| | |
|
33634 |
|
Anyone heard from z3peru....hope okay..eom |
GN |
moneyonomics
|
|
3 |
1/25/2021 11:42:49 PM |
|
| | |
|
33633 |
|
How is Lymphoseek being used in breast cancer surgery advancements such as the SCOUT® Radar Localization System |
GN |
moneyonomics
|
|
7 |
1/25/2021 11:38:28 PM |
|
| | |
|
33632 |
|
TA |
TA |
co3aii
|
|
2 |
1/25/2021 3:57:08 PM |
|
| | |
|
33631 |
|
Siamon Gordon MT/NAVB SAB:50 years later where are we?..now in a position to decipher functions of macrophages in every tissue..possible manipulation for therapeutic purposes, converting tumor-promoting trophic macrophage..to..cytocidal one or converse... |
GN |
moneyonomics
|
|
5 |
1/24/2021 9:15:10 PM |
|
| | |
|
33630 |
|
Sends positive signal for RA Dx P3 plans! Confirmation today on how difficult it was/strong accomplishment it was for the RA Dx P2b to be completed in ~21 original planned months! |
GN |
moneyonomics
|
|
7 |
1/22/2021 9:06:57 PM |
|
| | |
|
33629 |
|
RE: ICR....internal lab resolved issues with molecule...patents issued...KS ongoing as oncology proof and other pre clinicals in process with some funding...~2 years to unfold therapeutics...most view this as the big reach to be invested for...eom |
GN |
moneyonomics
|
|
5 |
1/21/2021 4:38:05 PM |
|
| | |
|
33628 |
|
ICR: Jan 14, 2021 completing RA Dx P2b arm 3, 16 patient data package, to be used in next several days to move forward with FDA. Will FDA 60 calander day review period end up to be 3, 4, 5, 6, 7, 8, or 9 weeks for response/meeting?...eom |
GN |
moneyonomics
|
|
4 |
1/21/2021 4:22:18 PM |
|
| | |
|
33627 |
|
Re: What a Joke |
GN |
clintock
|
|
0 |
1/21/2021 2:28:22 PM |
|
| | |
|
33626 |
|
ICR: RA Synovial Tissue comparison of quantitative TIL analysis of imaging vs Immunohistochemical from biopsy trial NAV3-32 to begin in Illinois beginning of Feb 2021..UK trail start pending for Covid clearance |
GN |
moneyonomics
|
|
7 |
1/20/2021 11:26:32 PM |
|
.
